Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
The article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that c...
Guardado en:
Autores principales: | Nina A. Petunina, Anna L. Terekhova, Ekaterina V. Goncharova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb4b48718f144cf18d9defcf7341b996 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
por: A. V. Simanenkova, et al.
Publicado: (2021) -
A PERFORMANCE STUDY OF BUS RAPID TRANSIT LITE: TOWARD A RESILIENT SEMARANG CITY
por: Tia D. INSANI, et al.
Publicado: (2021) -
Canagliflozin review – safety and efficacy profile in patients with T2DM
por: Jakher H, et al.
Publicado: (2019) -
Evaluación del cuestionario SF-12: verificación de la utilidad de la escala salud mental
por: Vera-Villarroel,Pablo, et al.
Publicado: (2014) -
Estructura Factorial y valores de referencia del WHOQoL-Bref en población adulta chilena
por: Urzúa M,Alfonso, et al.
Publicado: (2013)